Doctors for Drug Policy Reform
Doctors for Drug Policy Reform, or D4DPR (formerly known as Doctors for Cannabis Regulation, or DFCR) is a 501(c)(3) non-profit organization that serves as a global voice for licensed health professionals and scientists advocating for evidence-based drug policies and best practices that advance public health, reduce stigma, and minimize harm. D4DPR leverage the expertise, compassion, and influence of licensed health professionals to enact changes in drug policy necessary to improve public health, human rights, social justice, and consumer protections. D4DPR, formerly DFCR, was founded in 2015 by David L. Nathan. In 2021, Dr. Bryon Adinoff, an addictionologist, researcher, and editor-in-chief of the American Journal of Drug and Alcohol Abuse succeeded Nathan to become D4DPR's second president.
| Abbreviation | D4DPR |
|---|---|
| Formation | September 30, 2015 |
| Type | NGO |
| Purpose | Evidence-based drug policies that support public health, human rights, social justice, and consumer protections |
| Headquarters | Washington, DC |
Region served | International |
President | Bryon Adinoff, MD, DLFAPA, DFAAAP |
Key people | David L. Nathan, MD, DFAPA (founder and past president) |
| Website | d4dpr.org |
Over the years, DFCR and D4DPR have had notable leaders, spokespeople, and subject matter experts, including Chris Beyrer, Joycelyn Elders, Lester Grinspoon, Peter Grinspoon, Carl Hart, Julie Holland, David C. Lewis, Ethan Nadelmann, David Nutt, Beny Primm, Andrew Solomon, Andrew Weil, and Ken Wolski.